TRIPLE

The Truth Behind Doximity's Promises The brass tacks of investing often boil down to trust—a commodity that's now in short supply over at Doximity, Inc. (NYSE: DOCS). Investors have been left hanging after promises of lucrative engagement signals turned out to be a mere pipe dream. Levi & Korsinsky, LLP sounds the alarm on what's shaping up to be a high-stakes class...

Behind the Curtain: What Do These Deals Mean for Shareholders? Sometimes, investing in a stock ain't just about numbers on a screen—it's about untangling the whole messy ball of yarn these companies hand you with a smile. We're looking at Dana Incorporated (NYSE: DAN), GoPro, Inc. (NASDAQ: GPRO), and Personalis, Inc. (NASDAQ: PSNL). They've all got deals on the table,...

The Turbulence Behind FLNC: A Hard Pill to Swallow Looks like Fluence Energy (NASDAQ: FLNC) has stumbled right into a mess that's leaving investors with a bitter aftertaste. A securities class action lawsuit has been thrown their way, shaking up any stability folks thought they had. Levi & Korsinsky, LLP laid down the gauntlet on behalf of the shareholders hoodwinked by...

A Fresh Bloom in Gilbert: French Florist Steps In Toss aside your preconceived notions of what a florist shop should be. When French Florist sets up shop, it's not just about selling flowers—they’re a game-changer in the floral industry. As of November 4, they've stamped their luxury mark in Gilbert, Arizona, courtesy of Ronny and Nicole Record, who aren’t your...

AI Agents: A New Frontier in Customer Service The world of customer service is about to see a major shake-up, folks. Parloa, with its roots deep in AI customer service innovation, and tech powerhouse OpenAI are teaming up to expand their partnership. This isn’t some pie-in-the-sky dream; this is about bringing real-life improvements to how businesses and customers...

Whistleblower Complaint Rocks Madrigal Let me tell you, today's chatter isn't for the faint-hearted investor. Madrigal Pharmaceuticals (NASDAQ: MDGL) is under scrutiny, and it's making waves. The gears started turning when their former Senior VP and Head of Clinical Development unloaded a bombshell: he reported dirt on Madrigal's safety and efficacy data for Rezdiffra,...

Nektar Therapeutics on the Investor Radar Here's the scoop in the biotech world: Nektar Therapeutics, that clinical-stage biotech pioneer, is stepping into the spotlight at not one, but two heavyweight investor gigs this November. Showcasing their hand not just means they'll draw the curtains on their groundbreaking pipeline, but it's a shot across the bow to remind us...

Conference Time: Will Clarivate Deliver the Goods? Grab your calendars, folks. November 18 is when Clarivate Plc is stepping into the spotlight at the RBC Capital Markets Global Technology, Internet, Media and Telecommunications Conference. Their bigwigs, Matti Shem Tov, the CEO, and Michael Easton, the CFO, will be there to spill the beans. They’re set to take the mike...

Breaking Ground in Creator Ecosystems MyyShop isn't just a player in the creator economy; it's trying to change the damned rules. By focusing intensely on co-creation and learning, MyyShop's putting its chips on creating an inclusive and sustainable space where creators aren't just participants but the ones calling the shots. Catalyzing Co-Creation Everybody in the game...

Charting VTech's Financial Waters Well, here we are – another chapter in the saga of VTech, the electronic learning product titan. This time, they've danced a jig of higher revenues, a sweet 5.6% jump to $1,046.9 million for the six months leading to September 2026. But hang on, the party's not all balloons and confetti. Profit margins? They're bobbing like a ship in a...

Assurant Stock Hits 52-Week Low In the midst of evolving market conditions, Assurant Inc. (NYSE: AIZ) has seen its stock price drop to a notable 52-week low of $19.85. This decline translates to a 1-year change of -2.2%, prompting investors to reassess their strategies. However, amid this downturn, Assurant continues to exhibit robust fundamentals, evidenced by its...

Ona Therapeutics Strengthens Leadership Team for Innovative Cancer Therapies Ona Therapeutics is making waves in the biotech industry with its recent strategic leadership appointments aimed at fast-tracking the development of innovative antibody-drug conjugates (ADCs). These ADCs are designed to target and destroy hard-to-treat cancer cells across various solid tumor...

New Jersey Digital Marketing Conference is Back! Mark your calendars for the much-anticipated return of the New Jersey Digital Marketing Conference (NJDMC) on October 23, 2025, at the historic Bell Works campus. This vibrant event aims to unite innovative marketers, industry leaders, and creative thinkers for an inspiring day filled with learning and networking. A Day of...

Hancock Health Partners with Revology for Enhanced Revenue Operations Hancock Health is excited to announce its partnership with Revology aimed at transforming its revenue cycle management (RCM) operations. This collaboration marks a significant step towards adopting advanced technology that promises to improve efficiency and transparency in the billing processes....

Middlefield Canadian Income PCC Overview Middlefield Canadian Income PCC, a respected entity in the financial sector, has been gaining attention among investors. This protected cell company, incorporated in Jersey with registration number 93546, operates under the legal entity identifier 2138007ENW3JEJXC8658. Known for its strategic investments, the company focuses on...